MustGrow Biologics (TSE:MGRO) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MustGrow Biologics has completed the acquisition of NexusBioAg, enhancing its position in the biological and regenerative agriculture sector. This strategic move allows MustGrow to expand its sales and marketing capabilities in Canada and potentially the U.S., leveraging NexusBioAg’s expertise and network. The acquisition is expected to create significant sales synergies and reduce distribution costs for MustGrow’s products.
For further insights into TSE:MGRO stock, check out TipRanks’ Stock Analysis page.